Manning & Napier Group's MDT Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 116,674 shares of Medtronic plc (MDT) worth $11.11 M, representing 0.14% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2016, adding 2.78 M shares. Largest reduction occurred in Q1 2017, reducing 1.11 M shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2015 | +2.67 M | New Buy | 2.67 M | $66.94 |
| Q4 2015 | +2.34 M | Add 87.74% | 5.02 M | $76.92 |
| Q1 2016 | +2.78 M | Add 55.41% | 7.8 M | $75.00 |
| Q2 2016 | -733,055 | Reduce 9.40% | 7.06 M | $86.77 |
| Q3 2016 | -404,040 | Reduce 5.72% | 6.66 M | $86.40 |
| Q4 2016 | +114,113 | Add 1.71% | 6.77 M | $71.23 |
| Q1 2017 | -1.11 M | Reduce 16.36% | 5.67 M | $80.56 |
| Q2 2017 | -466,989 | Reduce 8.24% | 5.2 M | $88.75 |
| Q3 2017 | +90,922 | Add 1.75% | 5.29 M | $77.77 |
| Q4 2017 | +4.93 M | Add 0.00% | 4.93 M | $80.75 |
| Q1 2018 | -249,618 | Reduce 5.06% | 4.68 M | $80.22 |
| Q2 2018 | -1.09 M | Reduce 23.20% | 3.6 M | $85.61 |
| Q3 2018 | -158,311 | Reduce 4.40% | 3.44 M | $98.37 |
| Q4 2018 | -269,735 | Reduce 7.84% | 3.17 M | $90.96 |
| Q1 2019 | +13,712 | Add 0.43% | 3.18 M | $91.08 |
| Q2 2019 | +145,641 | Add 4.57% | 3.33 M | $97.39 |
| Q3 2019 | -225,499 | Reduce 6.77% | 3.1 M | $108.62 |
| Q4 2019 | -684,703 | Reduce 22.06% | 2.42 M | $113.45 |
| Q1 2020 | -1.03 M | Reduce 42.38% | 1.39 M | $90.18 |
| Q2 2020 | -2,136 | Reduce 0.15% | 1.39 M | $91.70 |
| Q3 2020 | -14,738 | Reduce 1.06% | 1.38 M | $103.92 |
| Q4 2020 | -18,021 | Reduce 1.31% | 1.36 M | $117.14 |
| Q1 2021 | +23,033 | Add 1.69% | 1.38 M | $118.13 |
| Q2 2021 | -377,411 | Reduce 27.31% | 1 M | $124.13 |
| Q3 2021 | +301,019 | Add 29.97% | 1.31 M | $125.35 |
| Q4 2021 | +8,467 | Add 0.65% | 1.31 M | $103.45 |
| Q1 2022 | -54,415 | Reduce 4.14% | 1.26 M | $110.95 |
| Q2 2022 | +251,436 | Add 19.96% | 1.51 M | $89.75 |
| Q3 2022 | +291 | Add 0.02% | 1.51 M | $80.75 |
| Q4 2022 | -26,429 | Reduce 1.75% | 1.48 M | $77.72 |
| Q1 2023 | +236,628 | Add 15.94% | 1.72 M | $80.62 |
| Q2 2023 | +591,792 | Add 34.38% | 2.31 M | $88.10 |
| Q3 2023 | +6,497 | Add 0.28% | 2.32 M | $78.36 |
| Q4 2023 | -785,820 | Reduce 33.87% | 1.53 M | $82.38 |
| Q1 2024 | -201,728 | Reduce 13.15% | 1.33 M | $87.15 |
| Q2 2024 | +325,794 | Add 0.00% | 325,793 | $78.71 |
| Q3 2024 | -6,506 | Reduce 2.00% | 319,287 | $90.03 |
| Q4 2024 | -30,170 | Reduce 9.45% | 289,117 | $79.88 |
| Q1 2025 | -21,667 | Reduce 7.49% | 267,450 | $89.86 |
| Q2 2025 | -37,968 | Reduce 14.20% | 229,482 | $87.17 |
| Q3 2025 | -112,808 | Reduce 49.16% | 116,674 | $95.24 |
Manning & Napier Group's Medtronic plc Investment FAQs
Manning & Napier Group first purchased Medtronic plc (MDT) in Q3 2015, acquiring 2,671,920 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Medtronic plc (MDT) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Medtronic plc (MDT) was in Q4 2017, adding 4,934,563 shares worth $398.46 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 116,674 shares of Medtronic plc (MDT), valued at approximately $11.11 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 0.14% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Medtronic plc (MDT) was 7,795,870 shares, as reported at the end of Q1 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.